ABSTRAm. Increased synthesis of type I collagen, leading to increased ratios of type I to type I11 collagen in the lungs, has been observed in the lungs of animals with experimental pulmonary fibrosis. Similar changes in collagen type ratios have been observed in lungs of humans dying of idiopathic pulmonary fibrosis and of adult respiratory distress syndrome. In this study, lung collagen type ratios were examined in infants with acute and chronic lung disease. Tissue from the right lower lobes of neonates was obtained post mortem. Specific collagen types were quantitated by solubilization of lung collagen with CNBr and fractionation of the resulting mixture of peptides by column chromatography and polyacrylamide gel electrophoresis. Ratios of type I/III collagen were calculated for each lung sample using two independent pairs of marker peptides for these determinations. In some cases the ratio of type V to type 111 collagen in these same lung samples was also quantitated. We observed a significant increase in the ratio of type I/III collagen in infants with a premortem diagnosis of chronic lung disease, usually preceded by respiratory distress syndrome. We also observed two infants with large changes in collagen type ratios who might have had pulmonary fibroplasia secondary to intrauterine lung disease. These data suggest that there may be several subsets of infants with respiratory distress syndrome, each having a different prognosis. (Pediatr Res 18:1176-1180, 1984 Abbreviations RDS, respiratory distress syndrome ARDS, adult respiratory distress syndrome CLD, chronic lung disease TPN, total parenteral nutrition prenatal administration of corticosteroids (1). Infants amicted with RDS often require mechanical ventilation with positive pressure and high partial pressures of oxygen to maintain respiratory exchange. Northway and his colleagues (2) described the complications associated with the therapy of RDS, calling the resulting syndrome bronchopulmonary dysplasia. A prominent pahological feature of this syndrome is the presence of thickened alveolar walls containing excess collagen fibers, i.e. interstitial pulmonary fibrosis. Northway et al. (2) recognized the possibility that bronchopulmonary dysplasia might be an iatrogenic disease secondary to oxygen toxicity. At the same time, Nash et al. (3) described pulmonary fibrosis associated with treatment of ARDS with oxygen therapy and mechanical ventilation.
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Our interest in collagen types in lungs of infants suffering from RDS stems from several observations in our laboratory. In different animal models of experimentally induced acute respiratory disease, we have observed shifts in the types of collagens being synthesized in lungs of affected animals, in conjunction with increased amounts of collagen (4) . We have recently shown (5) that lungs from patients with ARDS also contain increased ratios of type I to type 111 collagen as compared with controls.
Seyer et al. (6) have previously reported that similar shifts of collagen type ratios occur in lungs from adult patients dying of idiopathic pulmonary fibrosis. In addition, Zapol and coworkers (7) have reported that lungs of patients with ARDS contain larger amounts of collagen than lungs from normal subjects.
In the present study, we report upon the ratio of collagen types in lungs from newborn infants dying with evidence of pulmonary fibrosis (seven of nine also having had previous RDS) as compared with the ratios in lungs from infants dying of other causes without pulmonary fibrosis. New methods for collagen typing are used to quantitate the relative amount of type V collagen present in some of these lungs, and to evaluate the ratio of type I to type 111 collagen independently of our previously used standard methods.
MATERIALS AND METHODS
Respiratory distress syndrome (hyaline membrane disease) is the leading cause of morbidity and mortality in prematurely born infants. Dramatic advances in our understanding of the pathophysiological basis of this disease (and its successful treatment in neonatal intensive care units) have led to a tremendous improvement in the prognosis for RDS. One such treatment has been Right lower lobes or pieces thereof of lungs from 19 human infants, three of whom were stillborn, were dissected out during routine autopsy examination and placed in a sealed polyvinylchloride container, frozen, and stored at -18" C. Specimens were later thawed, weighed, and subjected to CNBr digestion, ionexchange chromatography on carboxymethyl cellulose, and polyacrylamide gel electrophoretic analysis according to the methods of Reiser and Last (4, 8, 9) . Using as index peptides a,(I)CB-8-3, a,(I)CB-8, a,(III)CB-8, and a,(V)CB-a, we were able to quantitate molar ratios of types I, 111, and V collagen in the tissue samples. In addition, we independently evaluated ratios of type I to type 111 collagen in the same tissue samples using as index peptides al(I)CB-7, a,(I)CB-3-7, and (~~(111)-CB-5 (1 0). Since tissue samples were usually not entire lobes, we did not attempt to quantitate collagen (hydroxyproline) content of the lung lobes. Cyanogen bromide quantitatively solubilized (>95%) the hydroxyproline from infant lung lobes under the conditions (1.5: 1 CNBr:dry weight of sample lung; 4 h of digestion at room temperature) used in this study.
Patients in this study had various neonatal (and prenatal) diseases. This protocol was approved by the University Committee on Ethics of Human Experimentation and informed consent was obtained from parents for acquisition of tissue for this study. Clinical and pathological diagnoses potentially relevant to lung collagen content and to cause(s) of death are listed for all of the subjects in this study in Table 1 . Group 1 died of causes other than pulmonary fibroplasia (chronic lung disease) and comprised 10 infants with a mean birth weight of 1899 + 959 g and a mean gestational age of 33.7 f 7.6 wk. Group 2 had clinically or pathologically defined pulmonary fibroplasia (1 1 -1 3), and included nine infants with a mean birth weight of 1232 + 863 g and a mean gestational age of 29.0 + 3.8 wk. All analyses were performed on coded samples without knowledge of the diagnosis for each infant. The results were subsequently correlated with clinical and histopathological information obtained from chart review by an individual other than the one performing the biochemical assays.
We examined several subsets of patients despite the relatively small numbers involved to seek correlations other than presence of infant RDS with changes in collagen type 11111 ratios. Medical records were reviewed to determine maternal gestational history including gestational complications and medication use, infant birth weight, gestational age, total ventilator days, diagnoses during life, medications utilized, radiographic, and histologic findings. Ventilator pressures and inspired percentage of oxygen were not analyzed due to the complex alterations that occurred with each patient.
RESULTS
We determined ratios of types I and 111 collagen from lungs of all infants in this study ( Table 2 ). For the control infants (n = lo), the group mean (rfrSD) was 1.62 + 0.14: 1.0 for the observed ratio of type Iltype I11 collagen. This value may be compared age at death and to total days of mechanical ventilation, as shown in Figure 1 . Two subjects were observed that had markedly increased collagen type 11111 ratios, only one of whom had clinical evidence of chronic lung disease. These individuals will be discussed below in more detail.
DISCUSSION
Up to 85% of the connective tissue mass of lung is collagen, of which type I and type 111 collagen are the predominant types (14) . Type I collagen, histologically defined "collagen" that stains with Masson's trichrome, is less compliant than type 111 collagen, which is thought to be part of the complex that stains as reticulin (15) . The lungs of infants with pulmonary fibroplasia contain relatively more type I than type 111 collagen as compared with lungs of infants dying of other causes (Table 2) . By analogy with adults dying of ARDS (5, 7), their lungs also presumably contain more collagen, and it is this excess type I collagen that accounts for the change in ratios of collagen types present (4). This excess of type I collagen accounts for the histologically apparent pulmonary fibrosis that is a hallmark of chronic lung disease in infants that cannot be rapidly weaned from ventilator support.
There are several potential difficulties in interpretation of the data from a clinical study such as this one. First, is the control group truly an appropriate one? It is older (34 + 8 versus 29 + 4 weeks of estimated gestational age) and larger ( 1.9 + 1 versus 1.2 + 0.9 kg) than the group composed of infants with CLD. Given that RDS is a disease of prematurity, there is little that one can do about this disparity except to note that the younger and smaller infants in the control group (Babies M. and Be.) had values for collagen type ratios that were typical of the group as a whole. In addition, the effect of a younger gestational age should be to decrease the type 11111 ratio, as there is relatively more type 111 collagen in fetal tissue than in adult (14) . Thus, any error introduced by having an older control group than CLD group should be to underestimate the true difference in collagen type ratios in their lungs. In addition, we did not observe any trend when correlating collagen type ratios and conceptual age of subjects (Fig. 1A) . Therefore, we can conclude that the control group was not only appropriate, but a conservative choice.
Second, is the chosen methodology appropriate? We have discussed elsewhere the need for CNBr peptide-mapping techniques to quantitate lung collagen types due to the extreme insolubility of lung collagen (4, 8, 9) , and have documented the validity of the methods used in the present study for tissue from TOTAL VENTILATOR DAYS Fig. 1 . Lung collagen type ratios as a function of ( A ) conceptual age at death or (B) total ventilator days (of treatment) for the 19 patients studied. Babies specifically discussed in the text include three with ratios of 4:l or greater as shown: these were Baby W., 28 wk and 5 ventilator days; Baby Bu., 41 wk and I I ventilator days; and Baby C., 49 wk and 147 ventilator days.
both laboratory rodents and human lungs (4, 5) . We have confirmed these results in the present study by introducing an independent evaluation of collagen type 11111 ratios, analysis of a,(I)CB-7, a,(I)-CB-3-7: aI(III)CB-5 ratios. As shown in Table 2 , these values are identical to those found with our previously used marker peptides, al(I)CB-8, aI(I)CB-8-3, and al(III)CB-8.
In our analysis of subgroups of infants in this study, we observed three lung samples with extremely high collagen type 11111 ratios (>4-5; cf: Fig. 1, A and B) . One infant's high collagen type ratio is consistent with a clinical history of RDS, bronchopulmonary dysplasia, and 147 days of ventilator support with a high percentage of inspired 02. The other two infants, however, seem to have anomalously high values for their collagen type ratios. How can we explain values greater than 5: 1 for these two infants, one "without clinically apparent chronic lung disease"? Based upon detailed review of their charts and histopathological review of autopsy tissue, we suggest that these two babies had "intrauterine shock lung." Both babies had evidence of asphyxia and CNS damage in utero. In the case of one of these infants (Baby Bu.), we can estimate occurrence of the intrauterine event from an amniocentesis performed 2 wk prior to the delivery date, as there were changes in the fetal activity stemming from that time. The pathological findings for this infant included CNS glial proliferation and evidence of fetallmaternal transfusion with fetal anemia, both conditions associated with prolonged in utero hypoxemia ( 19) .
Type V/III collagen ratios in control lungs did not differ significantly from ratios in lungs from neonates with CLD (Table  2) . However, the relatively small amount of type V collagen in the lung (less than 2-3% of the total lung collagen) and the low molar yield (about 10%) of the marker peptide cu,(V)CB-a (9) make this a very insensitive assay for small changes in type V collagen content of the lung. Clearly, the peptide mapping methods for type V collagen must be refined to increase the signal-tonoise ratio in this assay before rigorous conclusions about relative ratios of this minor collagen type can be drawn. Qualitative changes in type V collagen in adult fibrotic lungs have been reported in immunofluorescence studies that have used anticollagen antibodies ( 16).
The highly significant association of changes of collagen type ratios ( Table 3) with TPN was probably factitious. The TPN sample was probably subject to a strong selection bias in that a chronically ill infant would be started on this therapeutic modality. We observed an inverse association with the use of corticosteroids, but in three of these four cases steroid treatment was used as an adjunctive therapy late in the course of the disease. An interesting and unexpected finding was a strong correlation between bacterial infection during mechanical ventilation and subsequent CLD. Congenital pneumonia was unrelated to CLD in this study. We may speculate that the infant with RDS and damaged pulmonary endothelium is a subject at high risk for bacterial proliferation in the lung, perhaps due to compromised host lung defenses accompanying this disease.
The results of Figure 1B seem to rule out any direct causal association between duration of mechanical ventilation and elevated ratios of type I to type 111 collagen in the lungs of the RDS group. It has not been possible to analyze 0 2 administration data in the same fashion due to the complex patterns of its usage, but we feel that it too can be ruled out as a direct causal factor based on its close correlation with ventilator usage (days) in most cases and our previous results in adults dying of diseases other than ARDS who required Oz therapy and ventilator assistance (5).
In conclusion, we have identified at least two groups of infants dying of CLD, one in which RDS and alterations of collagen synthesis apparently lead to pulmonary fibrosis, and a second group in which very high levels of type I collagen synthesis may have occurred in utero after prolonged fetal hypoxemia. It is therefore possible that increased lung collagen content in CLD after RDS in neonates, as well as ARDS, is not due to oxygen therapy and mechanical ventilation with barotrauma, but to the underlying disease itself. It is possible that in neonates at high risk for CLD pharmacological intervention at the time of initial injury with drugs that alter collagen synthesis or deposition might be appropriate therapy for the prevention of lung fibroplasia. Steroids have been shown to decrease collagen synthesis is damaged animal lung (17) and, in some studies, to improve pulmonary function in human infants with bronchopulmonary dysplasia (1 8) . The possibility that corticosteroids might be effective in decreasing the rate of collagen synthesis in the lung if utilized prior to the injuring stimulus or during the phase of acute injury may warrant a clinical trial in neonates that are at high risk for pulmonary fibroplasia.
